645 related articles for article (PubMed ID: 15523091)
1. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
[TBL] [Abstract][Full Text] [Related]
2. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes.
Gijsens A; Derycke A; Missiaen L; De Vos D; Huwyler J; Eberle A; de Witte P
Int J Cancer; 2002 Sep; 101(1):78-85. PubMed ID: 12209592
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic activity of hypericin in human urinary bladder carcinoma cells.
Kamuhabwa AR; Agostinis P; D'Hallewin MA; Kasran A; de Witte PA
Anticancer Res; 2000; 20(4):2579-84. PubMed ID: 10953329
[TBL] [Abstract][Full Text] [Related]
4. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
Kamuhabwa AA; Roskams T; Baert L; De Witte PA
Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
[TBL] [Abstract][Full Text] [Related]
5. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
[TBL] [Abstract][Full Text] [Related]
7. Distribution of photosensitizers in bladder cancer spheroids: implications for intravesical instillation of photosensitizers for photodynamic therapy of bladder cancer.
Xiao Z; Hansen CB; Allen TM; Miller GG; Moore RB
J Pharm Pharm Sci; 2005 Sep; 8(3):536-43. PubMed ID: 16401399
[TBL] [Abstract][Full Text] [Related]
8. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
[TBL] [Abstract][Full Text] [Related]
10. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
Xiao Z; Brown K; Tulip J; Moore RB
J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
[TBL] [Abstract][Full Text] [Related]
11. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.
Paszko E; Vaz GM; Ehrhardt C; Senge MO
Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666
[TBL] [Abstract][Full Text] [Related]
12. Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivo.
Huygens A; Crnolatac I; Maes J; Van Cleynenbreugel B; Van Poppel H; Roskams T; de Witte PA
BJU Int; 2007 Nov; 100(5):1176-81. PubMed ID: 17868424
[TBL] [Abstract][Full Text] [Related]
13. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
Huygens A; Crnolatac I; Develter J; Van Cleynenbreugel B; Van der Kwast T; de Witte PA
J Urol; 2008 May; 179(5):2014-9. PubMed ID: 18355860
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects.
Gupta S; Dwarakanath BS; Chaudhury NK; Mishra AK; Muralidhar K; Jain V
J Cancer Res Ther; 2011; 7(3):314-24. PubMed ID: 22044814
[TBL] [Abstract][Full Text] [Related]
15. Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
Harris NM; Anderson WR; Lwaleed BA; Cooper AJ; Birch BR; Solomon LZ
Cancer; 2003 Jan; 97(1):71-8. PubMed ID: 12491507
[TBL] [Abstract][Full Text] [Related]
16. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
[TBL] [Abstract][Full Text] [Related]
17. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
[TBL] [Abstract][Full Text] [Related]
18. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
[TBL] [Abstract][Full Text] [Related]
19. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]